GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (ASX:TRI) » Definitions » EV-to-FCF

TrivarX (ASX:TRI) EV-to-FCF : -3.92 (As of Apr. 03, 2025)


View and export this data going back to 2001. Start your Free Trial

What is TrivarX EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, TrivarX's Enterprise Value is A$6.23 Mil. TrivarX's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-1.59 Mil. Therefore, TrivarX's EV-to-FCF for today is -3.92.

The historical rank and industry rank for TrivarX's EV-to-FCF or its related term are showing as below:

ASX:TRI' s EV-to-FCF Range Over the Past 10 Years
Min: -12.24   Med: -1.06   Max: 0.4
Current: -4.46

During the past 13 years, the highest EV-to-FCF of TrivarX was 0.40. The lowest was -12.24. And the median was -1.06.

ASX:TRI's EV-to-FCF is ranked worse than
100% of 393 companies
in the Healthcare Providers & Services industry
Industry Median: 16.99 vs ASX:TRI: -4.46

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-03), TrivarX's stock price is A$0.012. TrivarX's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.004. Therefore, TrivarX's PE Ratio (TTM) for today is At Loss.


TrivarX EV-to-FCF Historical Data

The historical data trend for TrivarX's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX EV-to-FCF Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.14 -2.91 -0.66 -1.39 -2.55

TrivarX Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.39 - -2.55 -

Competitive Comparison of TrivarX's EV-to-FCF

For the Health Information Services subindustry, TrivarX's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TrivarX's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where TrivarX's EV-to-FCF falls into.


;
;

TrivarX EV-to-FCF Calculation

TrivarX's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6.229/-1.59
=-3.92

TrivarX's current Enterprise Value is A$6.23 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TrivarX's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-1.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX  (ASX:TRI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

TrivarX's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.012/-0.004
=At Loss

TrivarX's share price for today is A$0.012.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TrivarX's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


TrivarX EV-to-FCF Related Terms

Thank you for viewing the detailed overview of TrivarX's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Traded in Other Exchanges
N/A
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.